share_log

Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression

Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression

Brainstorm Cell Therapeutics宣佈發表經同行評審的肌肉和神經三期生物標誌物數據,這表明Debamestrocel或NuroWN可能會影響肌萎縮性側索硬化症中預測疾病進展的關鍵生物標誌物
Benzinga ·  04/10 18:02

Brainstorm Cell Therapeutics Announced Peer-reviewed Publication Of Phase 3 Biomarker Data In Muscle And Nerve Suggesting That Debamestrocel Or NurOwn May Impact Key Biomarkers In Amyotrophic Lateral Sclerosis That Are Predictive Of Disease Progression

Brainstorm Cell Therapeutics宣佈發表經同行評審的肌肉和神經三期生物標誌物數據,這表明Debamestrocel或NuroWN可能會影響肌萎縮性側索硬化症中預測疾病進展的關鍵生物標誌物

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論